Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors

Stopped Pfizer has made an internal business decision to not continue further development of PF-07209960. This decision was not based on safety or regulatory considerations

Conditions

• Non-small-cell Lung Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Renal Cell Carcinoma
• Urothelial Carcinoma
• Colorectal Carcinoma
• Ovarian Carcinoma

Interventions

• BIOLOGICAL: PF-07209960

Sponsor

Pfizer